Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease
血液生物标志物证实，主观认知衰退（SCD）是阿尔茨海默病NIA-AA框架内一个独特的分子和临床阶段。
期刊:Molecular Psychiatry
影响因子:10.1
doi:10.1038/s41380-025-03021-0
Mengel, David; Soter, Ester; Ott, Julia Maren; Wacker, Madeleine; Leyva, Alejandra; Peters, Oliver; Hellmann-Regen, Julian; Schneider, Luisa-Sophie; Wang, Xiao; Priller, Josef; Spruth, Eike; Altenstein, Slawek; Schneider, Anja; Fliessbach, Klaus; Wiltfang, Jens; Hansen, Niels; Rostamzadeh, Ayda; Düzel, Emra; Glanz, Wenzel; Incesoy, Enise I; Buerger, Katharina; Janowitz, Daniel; Ewers, Michael; Perneczky, Robert; Rauchmann, Boris; Teipel, Stefan; Kilimann, Ingo; Laske, Christoph; Sodenkamp, Sebastian; Spottke, Annika; Brustkern, Johanna; Brosseron, Frederic; Wagner, Michael; Stark, Melina; Kleineidam, Luca; Shao, Kai; Lüsebrink, Falk; Yakupov, Renat; Schmid, Matthias; Hetzer, Stefan; Dechent, Peter; Scheffler, Klaus; Berron, David; Jessen, Frank; Synofzik, Matthis
